Resp other modalities

Aus coViki
Version vom 30. September 2020, 14:41 Uhr von Ossip Groth (Diskussion | Beiträge)
(Unterschied) ← Nächstältere Version | Aktuelle Version (Unterschied) | Nächstjüngere Version → (Unterschied)
Wechseln zu: Navigation, Suche


31560483 2019. Oxigenoterapia con canula nasal de alto flujo en lactantes con infeccion respiratoria baja aguda. Experiencia en hospitales de la Ciudad de Buenos Aires.
32671470 2020. Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure.
32737522 2020. Monitoring of high-flow nasal cannula for SARS-CoV-2 severe pneumonia: less is more, better look at respiratory rate.
32758000 2020. High Flow Nasal Canula in Critically Ill Severe COVID-19 Patients.
32753062 2020. Compared to NIPPV, HFNC is more dangerous regarding aerosol dispersion and contamination of healthcare personnel: we are not sure.
32826432 2020. High-Flow Nasal Oxygen in Coronavirus Disease 2019 Patients With Acute Hypoxemic Respiratory Failure: A Multicenter, Retrospective Cohort Study.
32847947 2020. Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure.
32880537 2020. The utility of high-flow nasal cannula oxygen therapy in the management of respiratory failure secondary to COVID-19 pneumonia.
C7283709 ?. Reducing aerosol dispersion by High Flow Therapy in COVID?19: High Resolution Computational Fluid Dynamics Simulations of Particle Behavior during High Velocity Nasal Insufflation with a Simple Surgical Mask.

Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis